100 results on '"Fadin, M"'
Search Results
2. Preparation of Luminophore CаTiO3:Pr3+ by Self-Propagating High-Temperature Synthesis
3. Preparation of MgAl2O4 Spinel Activated with Manganese Ions by Self-Propagating High-Temperature Synthesis.
4. Products of reaction between tetrabromo-substituted ortho- and para-hydroxybenzoic acids and sodium nitrite in CH3COOH
5. Rearrangements during nitrosodecarboxylation of isomeric dibromohydroxybenzoic acids
6. PO-29 Plasma levels of procoagulant and anticoagulant factors in patients with acute cancer-associated thrombosis
7. Preparation of Luminophore CаTiO3:Pr3+ by Self-Propagating High-Temperature Synthesis.
8. Uneventful coronary artery bypass surgery without prophylactic replacement therapy in a patient with a novel heterozygous FVII gene deletion
9. Maximum defect of an admissible octahedron in a rational lattice
10. O007: Type of combined contraceptives and the risk of venous thromboembolism in antithrombin, protein C and protein S deficient women: a prospective cohort study
11. Synthesis and some transformations of polybrominated quinone diazides
12. Hypercoagulability in cirrhotic patients with hepatocellular carcinoma (HCC) and portal vein thrombosis (PVT)
13. Whole blood thromboelastometry profiles in patients undergoing major orthopaedic surgery
14. Comparison of three different prothrombin complex concentrates efficacy, in reversal of anti-vitamin K effect in patients under oral anticoagulant treatment: an in vitro study
15. Hemostatic imbalance does not predict response to anticoagulant therapy in cirrhosis patients with portal vein thrombosis (PVT)
16. Factor VIIa/antithrombin complexes in cirrhotics with and without portal vein thrombosis: a possibly marker of increased thrombothic risk?
17. The Malmo polymorphism of coagulation factor IX (FIX) and the risk of venous thrombosis
18. Thrombin Generation In Patients With Portal Vein Thrombosis (pvt) With and Without Cirrhosis
19. 'In vitro' effect of enoxaparin on thrombin generation in plasma of cirrhotic patients at different stages of liver disease
20. Splanchnic venous thrombosis and thrombophilia: a case-control study
21. Endothelial circulating microparticles in thromboembolism and cancer
22. Dynamic whole blood coagulation profile in eight severe (homozygous) factor V deficient subjects
23. Coagulation assessment by rotation thromboelastometry (ROTEM) analysis in patients with splanchnic vein thrombosis with and without hepatic cirrhosis
24. Valutazione dei test fibrinolitici in pazienti a rischio di VOD dopo trapianto di cellule staminali ematopoietiche: studio in una popolazione pediatrica
25. Role of PAI-1 in the differential diagnosis of hepatic veno-occlusive disease complicating hematopoietic stem cell transplantation: study in a pediatric population
26. Hypercoagulable whole blood rotation thromboelastometry (ROTEM®) profile in 40 cynomolgus monkeys
27. Synthesis of protein s by human megakaryocytes
28. Comparison of thrombin generation between humans and cynomolgus monkeys
29. Platelet protein S antigen levels in congenital protein S deficiency
30. Venous thromboembolism and antiphospholipids antibodies toward protein C/protein S system: a case control study
31. ROtation ThromboElastoMetry profile in monitoring the treatment of severe acquired haemophilia A: report on a 78-year-old woman with life threatening bleedings
32. Portal vein thrombosis in cirrhosis: Predictors of successful anticoagulation therapy
33. Hypercoagulability in cirrhotic patients with hepatocellular carcinoma (HCC) and portal vein thrombosis (PVT)
34. O32 PROSPECTIVE EVALUATION OF THE CORRELATION BETWEEN HEMOSTATIC ALTERATIONS AND INCIDENCE OF PORTAL VEIN THROMBOSIS IN PATIENTS WITH LIVER CIRRHOSIS AND HEPATOCELLULAR CARCINOMA
35. OC.04.1 PROSPECTIVE EVALUATION OF THE CORRELATION BETWEEN HEMOSTATIC STATUS AND INCIDENCE OF PORTAL VEIN THROMBOSIS IN PATIENTS WITH LIVER CIRRHOSIS AND HEPATOCELLULAR CARCINOMA
36. Hemostatic status and portal vein thrombosis (PVT) in cirrhotic patients with hepatocellular carcinoma (HCC)
37. Predictive value of antithrombin III Levels on the outcome of a porcine renal xenografts trasplanted primated
38. Value of protein C and protein S levels for predicting the outcome of porcine renal xengrafts transplanted into primates
39. Anti-thrombin III levels in cynomolgus monkey recipients of life-supporting porcine renal xenograft
40. 188 THROMBIN GENERATION IN PATIENTS WITH PORTAL VEIN THROMBOSIS (PVT) WITH AND WITHOUT CIRRHOSIS
41. PO-30 Procoagulant phospholipids in patients with venous thromboembolism and cancer
42. PO-41 Role of PAI-1 in the differential diagnosis of hepatic veno-occlusive disease complicating hematopoietic stem cell transplantation: study in a pediatric population
43. ChemInform Abstract: Rearrangements During Nitrosodecarboxylation of Isomeric Dibromohydroxybenzoic Acids.
44. Antithrombin III levels in cynomolgus monkey recipients of a life-supporting porcine renal xenograft
45. Recombinant thromboplastin is slightly more sensitive to factor VII Padua than standard thromboplastins of human origin
46. Cabergoline versus bromocriptine in suppression of lactation after cesarean delivery.
47. Prevalence of Antiphospholipid Antibodies and Lupus Anticoagulant in Juvenile Patients with Objectively Documented Deep-Vein Thrombosis.
48. GISSI-3 - EFFECTS OF LISINOPRIL AND TRANSDERMAL GLYCERYL TRINITRATE SINGLY AND TOGETHER ON 6-WEEK MORTALITY AND VENTRICULAR-FUNCTION AFTER ACUTE MYOCARDIAL-INFARCTION
49. ChemInform Abstract: Rearrangements During Nitrosodecarboxylation of Isomeric Dibromohydroxybenzoic Acids.
50. A prediction model for successful anticoagulation in cirrhotic portal vein thrombosis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.